Related references
Note: Only part of the references are listed.Efficacy and safety of microbial transglutaminase-induced scleral stiffening in vivo
Xiaona Sun et al.
EXPERIMENTAL EYE RESEARCH (2023)
Roles and potential clinical implications of tissue transglutaminase in cardiovascular diseases
Shiqi Chen et al.
PHARMACOLOGICAL RESEARCH (2022)
Scleral remodeling in myopia development
Y. Qi et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2022)
Inhibiting Transglutaminase 2 Mediates Kidney Fibrosis via Anti-Apoptosis
Jong-Joo Moon et al.
BIOMEDICINES (2022)
Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis
Ting Su et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Functional integration of eye tissues and refractive eye development: Mechanisms and pathways
Jody A. Summers et al.
EXPERIMENTAL EYE RESEARCH (2021)
Substrates, inhibitors, and probes of mammalian transglutaminase 2
Ruize Zhuang et al.
ANALYTICAL BIOCHEMISTRY (2020)
Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma
Seon-Hyeong Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia
Sangeethabalasri Pugazhendhi et al.
CLINICAL OPHTHALMOLOGY (2020)
Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
Richard L. Eckert
MOLECULAR CARCINOGENESIS (2019)
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection
I. Palucci et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Transglutaminase 2 Promotes Migration and Invasion of Lung Cancer Cells
Hung-Tsung Lee et al.
ONCOLOGY RESEARCH (2018)
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease
Stefania Martucciello et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target
Navneet Agnihotri et al.
AMINO ACIDS (2017)
Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain
Jorunn Stamnaes et al.
FEBS JOURNAL (2016)
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Brien A. Holden et al.
OPHTHALMOLOGY (2016)
Animal models in myopia research
Frank Schaeffel et al.
CLINICAL AND EXPERIMENTAL OPTOMETRY (2015)
Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization
Jorunn Stamnaes et al.
PLOS ONE (2015)
Transglutaminase 2 and neuroinflammation
Riccardo Ientile et al.
AMINO ACIDS (2015)
Transglutaminase 2 and Its Role in Pulmonary Fibrosis
Keith C. Olsen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Focus on Molecules: Transglutaminase 2
Tara Tovar-Vidales et al.
EXPERIMENTAL EYE RESEARCH (2011)
Prevalence and risk factors for refractive errors and ocular biometry parameters in an elderly Asian population: the Singapore Longitudinal Aging Study (SLAS)
C. S. H. Tan et al.
EYE (2011)
Transglutaminases (TGs) in Ocular and Periocular Tissues: Effect of Muscarinic Agents on TGs in Scleral Fibroblasts
V. A. Barathi et al.
PLOS ONE (2011)
Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications
R. J. Collighan et al.
AMINO ACIDS (2009)
Role of Transglutaminase 2 in Liver Injury via Cross-linking and Silencing of Transcription Factor Sp1
Hideki Tatsukawa et al.
GASTROENTEROLOGY (2009)
Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity
Minati Satpathy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice
Tsai-Ching Hsu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury
Matthew Siegel et al.
PLOS ONE (2008)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Expression of collagen-binding integrin receptors in the mammalian sclera and their regulation during the development of myopia
Neville A. McBrien et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Effects of muscarinic antagonists on ZENK expression in the chicken retina
M Bitzer et al.
EXPERIMENTAL EYE RESEARCH (2006)
Tissue transglutaminase (TG2) - a wound response enzyme
D Telci et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Role of protein modifications mediated by transglutaminase 2 in human viral diseases
JH Jeon et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Myopia and associated pathological complications
SM Saw et al.
OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2005)
One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia
DTH Tan et al.
OPHTHALMOLOGY (2005)
Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses
P Stephens et al.
JOURNAL OF CELL SCIENCE (2004)
Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine
JH Jeon et al.
EMBO JOURNAL (2003)
Variable effects of previously untested muscarinic receptor antagonists on experimental myopia
WA Luft et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Inhibition of myopia development in chicks using himbacine:: a role for M4 receptors?
CL Cottriall et al.
NEUROREPORT (2001)
Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies
J Herkel et al.
JOURNAL OF AUTOIMMUNITY (2001)
Share Paper
